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Association Between Carotid Plaque Characteristics and
Subsequent Ischemic Cerebrovascular Events
A Prospective Assessment With MRI—Initial Results
Norihide Takaya, MD, PhD; Chun Yuan, PhD; Baocheng Chu, MD, PhD; Tobias Saam, MD;
Hunter Underhill, MD; Jianming Cai, MD; Nam Tran, MD; Nayak L. Polissar, PhD; Carol Isaac, RVT;
Marina S. Ferguson, MT; Gwenn A. Garden, MD, PhD; Steven C. Cramer, MD;
Kenneth R. Maravilla, MD; Beverly Hashimoto, MD; Thomas S. Hatsukami, MD
Background and Purpose—MRI is able to quantify carotid plaque size and composition with good accuracy and
reproducibility and provides an opportunity to prospectively examine the relationship between plaque features and
subsequent cerebrovascular events. We tested the hypothesis that the characteristics of carotid plaque, as assessed by
MRI, are possible predictors of future ipsilateral cerebrovascular events.
Methods—A total of 154 consecutive subjects who initially had an asymptomatic 50% to 79% carotid stenosis by
ultrasound with 12 months of follow-up were included in this study. Multicontrast-weighted carotid MRIs were
performed at baseline, and participants were followed clinically every 3 months to identify symptoms of cerebrovascular
events.
Results—Over a mean follow-up period of 38.2 months, 12 carotid cerebrovascular events occurred ipsilateral to the index
carotid artery. Cox regression analysis demonstrated a significant association between baseline MRI identification of the
following plaque characteristics and subsequent symptoms during follow-up: presence of a thin or ruptured fibrous cap
(hazard ratio, 17.0; P0.001), intraplaque hemorrhage (hazard ratio, 5.2; P0.005), larger mean intraplaque hemorrhage area
(hazard ratio for 10 mm2 increase, 2.6; P0.006), larger maximum %lipid-rich/necrotic core (hazard ratio for 10% increase,
1.6; P0.004), and larger maximum wall thickness (hazard ratio for a 1-mm increase, 1.6; P0.008).
Conclusions—Among patients who initially had an asymptomatic 50% to 79% carotid stenosis, arteries with thinned or
ruptured fibrous caps, intraplaque hemorrhage, larger maximum %lipid-rich/necrotic cores, and larger maximum wall
thickness by MRI were associated with the occurrence of subsequent cerebrovascular events. Findings from this
prospective study provide a basis for larger multicenter studies to assess the risk of plaque features for subsequent
ischemic events. (Stroke. 2006;37:818-823.)
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The vulnerability of an atherosclerotic plaque to rupture isbelieved to be related to its intrinsic composition such as
the size of the lipid core and presence of intraplaque hemor-
rhage.1,2 Several prospective studies using ultrasound have
shown that echolucent carotid plaques are associated with
increased risk for cerebrovascular events.3–6 Echolucent
plaques are known to have a higher content of lipid and
hemorrhage than do echogenic plaques, which contain more
calcification and fibrous tissue. However, B-mode ultrasound
is still challenged when distinguishing between hemorrhage
and lipid content of the plaque.7 A number of studies have
shown that multicontrast-weighted MRI is able to distinguish
these critical plaque tissue characteristics and the surface
status of plaque in the carotid artery, using histology as the
gold standard.8–11 In addition, improved technology and
resolution have resulted in the capacity to quantify plaque
components.12,13 This combination of accurate detection and
quantification produced a recent study showing that hemor-
rhage into the carotid atherosclerotic plaque is significantly
associated with more rapid progression in wall and lipid-rich
necrotic core (LR/NC) size, as well as more rapid progression
in luminal stenosis.14
The current challenge for MRI is to predict cerebrovascular
events among asymptomatic patients with hemodynamically
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significant carotid stenosis using plaque composition as the
determinant of vulnerability to stroke. The aim of this study
was to test the hypothesis that MRI identification of specific
plaque characteristics, such as the presence of intraplaque
hemorrhage, a large LR/NC, or a thinned/ruptured fibrous
cap, is associated with the development of subsequent ipsi-
lateral carotid cerebrovascular events.
Subjects and Methods
Study Population
A total of 183 consecutive cases with12 months of follow-up were
selected from an ongoing prospective serial carotid MRI study
referred to as PRIMARI. Subjects for PRIMARI were recruited from
the diagnostic vascular ultrasound laboratories at the University of
Washington Medical Center, Veterans Affairs Puget Sound, and the
Virginia Mason Medical Center after obtaining informed consent.
The study procedures and consent forms were reviewed and ap-
proved by the institutional review board of each site. Inclusion
criteria for PRIMARI include: (1) 50% to 79% carotid stenosis by
duplex ultrasound; and (2) asymptomatic with regard to their carotid
artery disease within the 6 months before enrollment in PRIMARI.
One side was chosen for serial MRI follow-up, referred to as the
index carotid artery. Exclusion criteria included: (1) previous carotid
endarterectomy on the index side; (2) previous neck irradiation; and
(3) contraindication for MRI.
Clinical Variables
Before the baseline MRI examination, study subjects were asked to
complete a detailed health questionnaire and physical examination.
The clinical end point for the study was a cerebrovascular event
including stroke or transient ischemic attack (TIA) in the region
supplied by the index carotid artery or ipsilateral amaurosis fugax.
Only events related to the index arteries were evaluated in the present
study. Follow-up continued after nonfatal events occurred. The date
of symptoms of clinical end points were ascertained every 3 months
by telephone interviews and confirmed through review of hospital
records. Subjects who gave a history suggestive of an ischemic event
were evaluated by a vascular surgeon (T.S.H.), and in suspected
cases, examined by a neurologist in a timely manner. Stroke was
considered to be of ischemic origin when cerebral hemorrhage was
excluded by neuroimaging. TIA was defined as a new-onset focal
neurological abnormality lasting 24 hours. Amaurosis fugax was
defined as acute onset of transient partial or complete monocular loss of
vision. Cardioemboic stroke was diagnosed according to Rochester
criteria.
MRI Protocol and Review
All patients were imaged at the University of Washington in a 1.5-T
GE Signa Scanner (Horizon EchoSpeed, version 5.8; General Elec-
tric Healthcare) using a phased-array surface coil (Pathway Medical
Technologies Inc). A previously published standardized protocol
was used to obtain 4 different contrast-weighted images (time of
flight [TOF], T1-weighted [T1W], proton density-weighted [PDW],
and T2-weighted [T2W]) of the carotid arteries centered at the
common carotid bifurcation on the index side.12 MRI parameters
were: T1W, double inversion-recovery, black-blood, 2D fast spin-
echo, repetition time (TR)/effective echo time (TE)800/10 ms,
echo train length (ETL)8; PDW and T2W, fast-spin echo, cardiac-
gated, TR3 or 4 cardiac R-R intervals, effective TE20 ms for
PDW and 40 ms for T2W, ETL6; and 3D TOF, TR/TE 23/3.8 ms,
flip angle 25°. Fat suppression was used for T1W, PDW, and T2W
images to reduce signals from subcutaneous fat. Images were
obtained with a field of view of 13 to 16 cm, matrix size of 256, slice
thickness of 2 mm, and 2 signal averages.
Image quality was rated per artery for each contrast-weighted
image on a 5-point scale (1poor, 5excellent) and cases in which
image quality 2 were excluded from the study. Two experienced
reviewers who were blinded to clinical outcome reviewed all
magnetic resonance images, and a consensus decision was reached
for each plaque feature.
Area measurements of the lumen, outer wall, and the tissue
components (LR/NC, calcium, and hemorrhage) were obtained using
a custom-designed imaging analysis tool.12 Wall area was calculated
as the difference between outer wall and lumen area. The carotid
bifurcation was used as a landmark for matching the 4 different
contrast-weighted images at each slice location. Areas of hemorrhage,
LR/NC, and calcification were identified using previously published
criteria that have been validated compared with histology.12,15
Mean areas per artery were calculated for lumen, wall, intraplaque
hemorrhage, LR/NC, and calcification. The mean area was defined
as the sum of areas from each cross-sectional location divided by the
number of cross-sectional locations analyzed. Slice-based analysis
was also performed for the minimum lumen area and maximal wall
thickness. The most diseased cross-sectional location, defined as the
site with the maximum proportion of the wall occupied by a LR/NC
(Max %LR/NC), was also calculated (%LR/NC100(LR/NC area/
wall area). Fibrous caps status was categorized as either “thick”
versus “thin or ruptured” using previously published, histologically
validated criteria.11
Statistical Analysis
The association of the time to a cerebrovascular event with carotid
artery characteristics as ascertained by MRI and other atherosclerotic
TABLE 1. Baseline Clinical Characteristics and MRI
Measurements (n154 patients)
Variable
Study Population
mean (SD) or %
Age, y 71.1 (9.3)
Male sex, % 82
Mean follow-up, mo 38.2 (17.1)
Body mass index 27.1 (4.4)
Smoking, %
Current 38
Former 49
Systolic blood pressure, mm Hg 144.2 (25.5)
Diastolic blood pressure, mm Hg 70.0 (12.4)
History of hypertension, % 75
History of diabetes, % 25
History of hypercholesterolemia, % 79
History of coronary artery disease, % 44
Currently on HMG-CoA reductase inhibitor, % 64
MRI measurements
% of arteries with lipid-rich/necrotic core 72
% of arteries with intraplaque hemorrhage 28
% of arteries with thin/ruptured fibrous cap 38
Mean lumen area per slice, mm2 61.2 (28.5)
Mean wall area per slice, mm2 87.8 (27.6)
Mean LR/NC area per slice, mm2 8.8 (11.6)
Mean calcium area per slice, mm2 3.4 (4.8)
Mean IPH area per slice, mm2 1.9 (5.2)
Maximum LR/NC area as % of wall area 20.3 (17.8)
Maximum wall thickness, mm 4.2 (1.5)
Minimum lumen area, mm2 15.4 (9.8)
Sample size varies slightly across variables attributable to missing values.
Values represent means (SD).
HMG-CoA indicates 3-hydroxy-3-methylglutaryl–coenzyme A.
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risk factors was analyzed using the Cox proportional hazards model
with the likelihood ratio test used to ascertain statistical significance.
Only univariate analyses (using 1 independent variable) were per-
formed with the Cox regression model. Meaningful multivariate
analyses could not be performed because of the limited number of
cases with an event. Results from Cox models are expressed as
hazard ratios (HRs) with 95% CIs. The Kaplan–Meier product-limit
method was used to estimate cumulative event-free rates in sub-
groups for graphical display depending on the presence of in-
traplaque hemorrhage and thin or ruptured fibrous cap. Data on
patient and artery characteristics were expressed as meanSD. All
calculations were made with SPSS 12.0 for Windows. Statistical
significance was defined as a value of P0.05.
Results
Among the 183 patients (183 arteries) available, 29 arteries
were excluded because of an image quality rating of 2.
Mean age of the 154 remaining participants was 71.1 years
(range 48.4 to 87.2), and 82% were male. Mean follow-up
time was 38.2 months. The baseline clinical characteristics
and baseline MRI findings are presented in Table 1. A total of
111 (72%) of the subjects had arteries containing an LR/NC,
and 43 (28%) had intraplaque hemorrhage into the necrotic
core. Thin or ruptured caps were observed in 58 subjects
(38%). During follow-up, 14 of the 154 individuals experi-
enced an ipsilateral ischemic cerebrovascular event (4 TIAs,
6 strokes, and 4 with ipsilateral amaurosis fugax). Among the
14 cases, 2 patients with a history of intermittent atrial
fibrillation had a stroke during follow-up that was felt by their
neurologist and cardiologist to be cardiogenic. These 2 cases
were not included as events in the analysis.
Among all of the baseline clinical and MRI variables listed
in Table 1, Cox regression analysis indicated that plaques
with intraplaque hemorrhage (HR, 5.2; 95% CI, 1.6 to 17.3;
P0.005), larger mean intraplaque hemorrhage area (HR for
10-mm2 increase, 2.6; 95% CI, 1.4 to 4.6; P0.006), thin or
ruptured fibrous cap (HR, 17.0; 95% CI, 2.2 to 132.0; P0.001),
larger maximum %LR/NC (HR for 10% increase, 1.6; 95% CI,
1.2 to 2.0; P0.004), and maximum wall thickness (HR for a
1-mm increase, 1.6; 95% CI, 1.1 to 2.3; P0.008) were
associated with the development of subsequent ischemic cere-
brovascular events (Table 2). Kaplan–Meier plots for the inci-
dence of ipsilateral cerebrovascular events demonstrated that
event-free survival was higher among plaques without in-
traplaque hemorrhage compared with those with intraplaque
hemorrhage at baseline (Figure 1) and among plaques with
intact, thick fibrous caps (Figure 2). Figure 3 shows a represen-
tative case of intraplaque hemorrhage with fibrous cap rupture
seen on baseline MRI examination. The subject went on to
develop an ipsilateral stroke 24 months later and subsequently
underwent carotid endarterectomy. Histological examination of
the corresponding cross-section demonstrates intraplaque hem-
orrhage with surface disruption.
Potential predictive factors were also analyzed within the
subgroup of plaques that had an LR/NC (n111 patients with
11 events). The presence of intraplaque hemorrhage (HR, 4.2;
95% CI, 1.1 to 16.0; P0.022), thin or ruptured fibrous cap
(HR, 8.6; 95% CI, 2.0 to 67.5; P0.007), larger mean
intraplaque hemorrhage area (HR for 10-mm2 increase, 2.3;
95% CI, 1.3 to 4.2; P0.017), and maximum %LR/NC (HR
Figure 1. Kaplan–Meier survival estimates of the proportion of
patients remaining free of ipsilateral cerebrovascular events for
subjects with (lower curve) and without (upper curve) intraplaque
hemorrhage. IPH indicates intraplaque hemorrhage.
TABLE 2. Relationship Between Risk Factors and Ipsilateral
Cerebrovascular Event During Follow-Up, Determined by
Cox Regression
Variable HR 95% CI P Value
Age, y 1.1 1.0–1.1 0.1
Gender 1.0 0.2–4.5 1.0
Body mass index 1.0 0.9–1.2 0.6
Systolic blood pressure 1.0 1.0–1.0 0.7
Diastolic blood pressure 1.0 1.0–1.0 0.8
History of hypertension 1.6 0.4–7.4 0.5
History of diabetes 1.0 0.3–3.8 1.0
History of hypercholesterolemia 1.1 0.3–5.2 0.9
History of coronary artery disease 1.2 0.4–3.8 0.7
HMG-CoA reductase inhibitor use 1.0 0.3–3.4 1.0
Presence of LR/NC 4.4 0.6–33.7 0.09
Presence of IPH 5.2 1.6–17.3 0.005
Presence of thin/ruptured FC 17.0 2.2–132.0 0.001
Mean lumen area* 1.2 0.9–1.5 0.2
Mean wall area† 1.1 0.9–1.4 0.3
Mean LR/NC area† 1.6 1.1–2.1 0.01
Mean calcium area† 2.4 0.9–6.1 0.1
Mean IPH area† 2.6 1.4–4.6 0.006
Maximum %LR/NC of wall‡ 1.6 1.2–2.0 0.004
Maximum wall thickness§ 1.6 1.1–2.3 0.008
Minimum lumen area* 1.3 0.7–2.5 0.4
IPH indicates intraplaque hemorrhage; FC, fibrous cap; HMG-CoA, 3-hydroxy-3-
methylglutaryl–coenzyme A.
*A 10-mm2 decrease; †a 10-mm2 increase; ‡a 10% increase; §a 1-mm
increase.
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for 10% increase, 1.5; 95% CI, 1.1 to 2.2; P0.021) were
significant predictors by Cox regression analysis.
Discussion
This study represents one of the first to prospectively exam-
ine the relationship between baseline carotid plaque features
identified by MRI and the development of subsequent carotid
cerebrovascular events. Among patients with initially asymp-
tomatic, hemodynamically significant carotid stenosis (50%
to 79% by duplex ultrasound), Cox regression analysis
showed that arteries with thin or ruptured fibrous caps,
intraplaque hemorrhage, larger maximum %LR/NC, and
larger maximum wall thickness had a significantly higher
likelihood of developing ipsilateral cerebrovascular events
during follow-up. These findings provide further evidence of
the utility of MRI for identifying the high-risk atherosclerotic
carotid plaque.
Intraplaque hemorrhage has long been recognized as a
component of the complex atherosclerotic plaque. Histolog-
ical studies published in the 1980s demonstrated an associa-
tion between the presence of intraplaque hemorrhage and a
history of TIA or stroke before carotid endarterectomy.16,17
However, the limitation of studies on excised specimens is
that they are retrospective and cannot quantify the risk of
future events. Several prospective ultrasound studies sug-
gested that echolucent plaques predict an increased risk of
subsequent ischemic cerebrovascular events.3–6 Advantages
of ultrasonography include low cost and widespread avail-
ability. However, studies on the accuracy of ultrasound for
identifying plaque composition have been conflicting, and
ultrasound cannot reliably distinguish hemorrhage from lipid
core.18–20 Our study found that the presence of intraplaque
hemorrhage was significantly associated with subsequent
carotid cerebrovascular events. However, the presence of an
LR/NC, which sometimes includes an intraplaque hemor-
rhage, was not significantly associated with the risk of an
event. An additional analysis comparing patients with an
LR/NC but without a hemorrhage (n68) versus all other
patients (n86) showed no significant association with the
risk of an event (HR, 0.4; P0.2). These findings suggest that
the ability to distinguish the LR/NC with intraplaque hemor-
rhage from the LR/NC without intraplaque hemorrhage may
be critical.
On the other hand, analysis of the size of the LR/NC, such
as the maximum %LR/NC of wall, was associated with future
events. When we evaluated the association between events
Figure 2. Kaplan–Meier survival estimates of the proportion of
patients remaining free of ipsilateral cerebrovascular events for
subjects with (lower curve) and without (upper curve) thin or
ruptured fibrous cap.
Figure 3. A representative case of
fibrous cap rupture and hemorrhage into
a carotid atherosclerotic plaque on
baseline MRI. The subject experienced
an ipsilateral stroke 24 months later and
subsequently underwent CEA. Signal
intensity patterns of hemorrhage (red
arrow in TOF) are hyperintensity on the
TOF and T1W images and hypointensity
(double arrowhead) and hyperintensity
(arrowhead) on the PDW/T2W images,
suggesting a mixed of type I and type II
intraplaque hemorrhage. A Mallory
trichrome-stained matching histology
section demonstrates the presence of
the hemorrhage (arrowhead and double
arrowhead) and surface disruption
(arrow). The hemorrhage near to the dis-
rupted surface (double arrowhead) is
more recent than the hemorrhage deep
in the plaque (arrowhead). Asterisks indi-
cate the lumen.
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and the presence of a larger LR/NC, defined as greater than
the mean of all plaques with a LR/NC (n111), Cox regression
univariate analysis demonstrated a significant association with
subsequent ipsilateral carotid cerebrovascular events (HR,
7.0; 95% CI, 1.9 to 26.5; P0.002).
It is well known that a thin or ruptured fibrous cap is an
important morphological component of the vulnerable ath-
erosclerotic plaque.1,2 Previous studies have shown that MRI
can distinguish thick, thin, and ruptured caps with good
sensitivity and specificity in vivo.11,21 In a retrospective
study, Yuan et al22 demonstrated that patients with thin and
ruptured fibrous caps were more likely to have had a recent
TIA or stroke (odds ratio, 10 and 23, respectively) compared
with plaques with thick caps identified by MRI. In line with
previous histological and retrospective imaging studies, find-
ings from our prospective study confirm the importance of
fibrous cap status in the development of future ischemic
complications.
The Asymptomatic Carotid Atherosclerosis Study (ACAS)
evaluated the efficacy of endarterectomy in patients with a
60% diameter reduction in asymptomatic carotid stenosis.23
More recently, the largest randomized trial of endarterectomy
for asymptomatic stenosis, the Medical Research Council
Asymptomatic Carotid Surgery Trial (ACST), published results
similar to ACAS.24,25 Both studies demonstrated absolute 5-year
risk reductions with surgery of 5.3% and 5.1%, respectively. It
is noteworthy that although there was a higher risk of stroke
in the medically treated group, the overwhelming majority of
subjects did not have an event. These findings highlight the
need for developing improved criteria for identifying the
characteristics of the high-risk carotid plaque, other than
degree of stenosis, to better select those with asymptomatic
carotid disease in need of surgical intervention.
In the present study, 2 cases were diagnosed as having a
cardiogenic stroke and were not included as events in the
analysis. However, even if we included those cases in the
analysis, the results did not change. Cox regression analysis
indicated that plaques with intraplaque hemorrhage (HR, 4.7;
95% CI, 1.6 to 14.0; P0.004), larger mean intraplaque
hemorrhage area (HR for 10-mm2 increase, 2.4; 95% CI, 1.4
to 4.1; P0.008), thin or ruptured fibrous cap (HR, 9.4; 95%
CI, 2.1 to 42.1; P0.001), larger maximum %LR/NC (HR for
10% increase, 1.4; 95% CI, 1.1 to 1.9; P0.01), and maximum
wall thickness (HR for a 1-mm increase, 1.6; 95% CI, 1.1 to 2.1;
P0.007) were associated with the events. A limitation of this
study is the small number of cerebrovascular events that oc-
curred during follow-up in our study population. The number
was too small to support a multivariate analysis. Nonetheless,
highly significant associations were observed, and these
findings form the basis and justification for larger, prospec-
tive studies to better define the risk of specific carotid plaque
features for TIA and stroke.
In conclusion, this prospective study indicates that a thin or
ruptured fibrous cap, intraplaque hemorrhage, larger maxi-
mum %lipid-rich/necrotic core, and larger maximum wall
thickness as identified by MRI are significantly associated
with the development of subsequent ipsilateral hemispheric
TIA, stroke, or amaurosis fugax in patients with an initially
asymptomatic, 50% to 79% carotid stenosis at baseline. If
reproduced in larger prospective studies, MRI may provide an
important tool for risk stratification and selection of candi-
dates for invasive therapy.
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